Characterization of CT-0508, an anti-HER2 chimeric antigen receptor macrophage (CAR-M), manufactured from patients enrolled in the phase 1, first in human, clinical trial of CT-0508

CT-0508 - CARISMA Therap

https://jitc.bmj.com/content/10/Suppl_2/A331

Michael Ball; Madison Kremp; Rehman Qureshi; Poonam Sonawane; Maggie Schmierer; Josh VanDuzer; Michael Lynch; Adam Pfendt; Melissa Christiano; Ken Locke; Ramona Swaby; Daniel Cushing; Michael Klichinsky; Thomas Condamine

Oct 6, 2022